Illumina (ILMN) Gets a Buy from RBC Capital
In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...
Illumina price target lowered to $128 from $247 at RBC Capital
RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s ...
Yahoo Finance1d
Illumina, Inc. (ILMN)
Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...
Illumina Lowers Outlook Due to China Sales Ban, to Cut $100 Million in Costs
(Reuters) - Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China ...
Benzinga.com9d
Demystifying Illumina: Insights From 11 Analyst Reviews
11 analysts have expressed a variety of opinions on Illumina ILMN over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments ...
U.S. News & World Report1mon
Illumina Forecasts 2025 Revenue Largely Below Estimates
(Reuters) - Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling subdued demand for its genetic tests and diagnostic tools ...
Yahoo Finance7d
Illumina, Inc. (ILMN)
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth year in a row to the Dow Jones Best-in-Class World Index and the Dow ...